Showing 1351-1360 of 1610 results for "".
- J-Code for Glaukos’ iDose TR Becomes Activehttps://modernod.com/news/cms-j-code-for-glaukos-idose-tr-becomes-active/2482340/Glaukos announced that the CMS Healthcare Common Procedure Coding System’s J-code—J7355—for the company’s iDose TR is effective. The J-code provides patient access and streamlines the coverage and payment process as Glaukos advances its commercial launch of the treatment.<
- Novartis Receives Permanent J-code for Beovuhttps://modernod.com/news/novartis-receives-permanent-j-code-for-beovu/2477192/Novartis announced that it has received a permanent J-code for Beovu (brolucizumab-dbll) injection, effective January 1, 2020. With the permanent J-code, retina specialists may now receive more timely reimbursement for Beovu injections, facilitating access for appropriate patients to this
- Glaukos Receives Permanent J-Code for iDose TRhttps://modernod.com/news/glaukos-receives-permanent-j-code-for-idose-tr/2482208/Glaukos announced that CMS has assigned a unique, permanent J-code (J7355) for iDose TR (travoprost intracameral implant) 75 mcg, a p
- OD-OS to Celebrate 10 Years of the Navilas Laser Systems at EURETINAhttps://modernod.com/news/od-os-to-celebrate-10-years-of-the-navilas-laser-systems-at-euretina/2479864/OD-OS, the inventor of the Navilas laser systems, is celebrating 10 years of retina navigation with expert sessions at the upcoming EURETINA 2018 conference in Vienna, September 21-25, booth C207. <
- In Memoriam: Jack J. Kanski, FRCS, FRCOphthhttps://modernod.com/news/in-memoriam-jack-j-kanski-frcs-frcophth/2476199/World-renowned ophthalmologist Jacek Jerzy Kanski (better known as Jack J. Kanski, FRCS, FRCOphth) died on January 5, 2019. Few authors have left behind so vast a legacy. His books have enabled tens of thousands of ophthalmologists around the world to pass their examinations and have served as re
- Apellis Receives Permanent J-Code for GA Drug Syfovrehttps://modernod.com/news/apellis-receives-permanent-j-code-for-ga-drug-syfovre/2481844/The U.S. Centers for Medicare & Medicaid Services (CMS) assigned a permanent and product-specific J-code (J2781) for Apellis Pharmaceuticals' Syfovre (pegcetacoplan injection), the first treatment for geographic atrophy (GA) secondary to age-related macular degeneration. The J-code f
- Product Specific J-Code for Omeros’ Omidria is Now in Effecthttps://modernod.com/news/product-specific-j-code-for-omeros-omidria-is-now-in-effect/2476927/Omeros announced that the product specific J-code for Omidria (phenylephrine and ketorolac intraocular solution) 1%/0.3% is now effective. Omidria is Omeros’ commercial drug marketed for use during cataract surgery to prevent miosis and reduce postoperative pain. The new permanent J-code f
- Opthea Names Quinton Oswald and Susan Orr, OD, to its Board of Directorshttps://modernod.com/news/opthea-names-quinton-oswald-and-susan-orr-od-to-its-board-of-directors/2480790/Opthea announced the appointment of Quinton Oswald and Susan Orr, OD, to its Board of Directors, effective immediately following election at a General Meeting of Shareholders on April 21st, 2022. Mr. Oswald and Dr. Orr have deep experience leading biotech companies and launching c
- OD-OS Introduces Teleguidance Software for Navilas 577s Navigated Retina Laserhttps://modernod.com/news/od-os-introduces-teleguidance-software-for-navilas-577s-navigated-retina-laser/2479491/OD-OS has launched additional remote access capabilities for its Navilas Laser System 577s to address common challenges in ophthalmology that were enhanced during the COVID-19 pandemic. The new teleguidance capabilities give doctors remote access to the device to pre-plan a retinal laser treatmen
- OD-OS to Showcase Navilas Navigated Retinal Laser Therapy at EURETINAhttps://modernod.com/news/od-os-to-showcase-navilas-navigated-retinal-laser-therapy-at-euretina/2476852/OD-OS will share clinical experiences with the Navilas 577s digital treatment platform this week at the EURETINA Congress in Paris. Navigated retinal laser therapy with the Navilas 577s allows for panretinal photocoagulation with uniform spot distribution, which is faster and less painful for pat